Skip to main content
. 2024 Feb 6;15:1336476. doi: 10.3389/fimmu.2024.1336476

Figure 1.

Figure 1

From a cohort of 19 newly-diagnosed GBM patient tumor samples, immunohistochemical stains to fibronectin-1 and decorin were obtained. Per review by a board-certified pathologist, fibronectin was enhanced in areas immediately adjacent to necrosis, while decorin was enhanced within the necrotic core of the tumor. Presented here are three representative samples. Samples were collected by the The Nervous System Tumor Bank at Northwestern University was used to collect all human samples under IRB number STU00202003.